The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology

Ítems similars

• COVID-19 and immunomodulator/immunosuppressant use in dermatology
  per: Price, Kyla N., et al.
  Publicat: (2020)
• Implications of the COVID-19 Pandemic for the Development and Update of Clinical Practice Guidelines: Viewpoint
  per: Steeb, Theresa, et al.
  Publicat: (2020)
• Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic—General Recommendation Based on Available Evidence
  per: De, Dipankar, et al.
  Publicat: (2020)
• COVID‐19 and immunosuppressive therapy in dermatology
  per: Schwartz, Robert A., et al.
  Publicat: (2020)
• Challenges of COVID‐19 pandemic for dermatology
  per: Wollina, Uwe
  Publicat: (2020)